Literature DB >> 33043837

The HMGA1-pseudogene7 shows oncogenic activity in vivo.

Marco De Martino1, Francesco Esposito1, Alfredo Fusco1.   

Abstract

We have recently reported that transgenic mice overexpressing the HMGA1-pseudogene7 develop hematological neoplasia marked by monoclonal B-cell populations, and diagnosed as Diffuse Large B-cell Lymphoma. These findings prove the HMGA1-pseudogene7 oncogenic role in vivo.

Entities:  

Keywords:  HMGA1 pseudogenes; ceRNA; transgenic mouse models

Mesh：

Substances：

Year:  2020        PMID： 33043837      PMCID： PMC7714516          DOI： 10.1080/15384101.2020.1829825

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


  26 in total

Review 1.  Emerging EZH2 Inhibitors and Their Application in Lymphoma.

Authors:  Jennifer K Lue; Jennifer E Amengual
Journal:  Curr Hematol Malig Rep       Date:  2018-10       Impact factor: 3.952

Review 2.  HMGA and Cancer: A Review on Patent Literatures.

Authors:  Marco De Martino; Alfredo Fusco; Francesco Esposito
Journal:  Recent Pat Anticancer Drug Discov       Date:  2019       Impact factor: 4.169

3.  HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas.

Authors:  Antonio Palumbo; Marco De Martino; Francesco Esposito; Filippo Fraggetta; Pedro N Neto; Priscila Valverde Fernandes; Izabella C Santos; Fernando L Dias; Luiz E Nasciutti; Nathalia Meireles Da Costa; Alfredo Fusco; Luís Felipe Ribeiro Pinto
Journal:  Histopathology       Date:  2018-03-09       Impact factor: 5.087

4.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.

Authors:  Laura Poliseno; Leonardo Salmena; Jiangwen Zhang; Brett Carver; William J Haveman; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

5.  HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism.

Authors:  Marco De Martino; Floriana Forzati; Marianna Marfella; Simona Pellecchia; Claudio Arra; Luigi Terracciano; Alfredo Fusco; Francesco Esposito
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

6.  The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism.

Authors:  Marco De Martino; Giuseppe Palma; Amalia Azzariti; Claudio Arra; Alfredo Fusco; Francesco Esposito
Journal:  Genes (Basel)       Date:  2017-11-17       Impact factor: 4.096

7.  Overexpression of HMGA1 Figures as a Potential Prognostic Factor in Endometrioid Endometrial Carcinoma (EEC).

Authors:  Antonio Palumbo Júnior; Vanessa Paiva Leite de Sousa; Francesco Esposito; Marco De Martino; Floriana Forzati; Fábio Carvalho de Barros Moreira; Tatiana de Almeida Simão; Luiz Eurico Nasciutti; Alfredo Fusco; Luis Felipe Ribeiro Pinto; Cláudia Bessa Pereira Chaves; Nathalia Meireles Da Costa
Journal:  Genes (Basel)       Date:  2019-05-15       Impact factor: 4.096

8.  HMGA1-pseudogene7 transgenic mice develop B cell lymphomas.

Authors:  Marco De Martino; Davide De Biase; Floriana Forzati; Sara Carmela Credendino; Giuseppe Palma; Antonio Barbieri; Claudio Arra; Orlando Paciello; Eugenio Gaudio; Maurilio Ponzoni; Gabriella De Vita; Paolo Chieffi; Francesco Bertoni; Alfredo Fusco; Francesco Esposito
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

9.  MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.

Authors:  Xiaoxue Tian; Jianping Song; Xiyu Zhang; Mingyao Yan; Shourong Wang; Yuqiong Wang; Limei Xu; Ling Zhao; Jian-Jun Wei; Changshun Shao; Beihua Kong; Zhaojian Liu
Journal:  Cell Death Dis       Date:  2020-03-03       Impact factor: 8.469

10.  Landscape of transcription in human cells.

Authors:  Sarah Djebali; Carrie A Davis; Angelika Merkel; Alex Dobin; Timo Lassmann; Ali Mortazavi; Andrea Tanzer; Julien Lagarde; Wei Lin; Felix Schlesinger; Chenghai Xue; Georgi K Marinov; Jainab Khatun; Brian A Williams; Chris Zaleski; Joel Rozowsky; Maik Röder; Felix Kokocinski; Rehab F Abdelhamid; Tyler Alioto; Igor Antoshechkin; Michael T Baer; Nadav S Bar; Philippe Batut; Kimberly Bell; Ian Bell; Sudipto Chakrabortty; Xian Chen; Jacqueline Chrast; Joao Curado; Thomas Derrien; Jorg Drenkow; Erica Dumais; Jacqueline Dumais; Radha Duttagupta; Emilie Falconnet; Meagan Fastuca; Kata Fejes-Toth; Pedro Ferreira; Sylvain Foissac; Melissa J Fullwood; Hui Gao; David Gonzalez; Assaf Gordon; Harsha Gunawardena; Cedric Howald; Sonali Jha; Rory Johnson; Philipp Kapranov; Brandon King; Colin Kingswood; Oscar J Luo; Eddie Park; Kimberly Persaud; Jonathan B Preall; Paolo Ribeca; Brian Risk; Daniel Robyr; Michael Sammeth; Lorian Schaffer; Lei-Hoon See; Atif Shahab; Jorgen Skancke; Ana Maria Suzuki; Hazuki Takahashi; Hagen Tilgner; Diane Trout; Nathalie Walters; Huaien Wang; John Wrobel; Yanbao Yu; Xiaoan Ruan; Yoshihide Hayashizaki; Jennifer Harrow; Mark Gerstein; Tim Hubbard; Alexandre Reymond; Stylianos E Antonarakis; Gregory Hannon; Morgan C Giddings; Yijun Ruan; Barbara Wold; Piero Carninci; Roderic Guigó; Thomas R Gingeras
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962
View more
  1 in total

1.  Pseudogene AK4P1 promotes pancreatic ductal adenocarcinoma progression through relieving miR-375-mediated YAP1 degradation.

Authors:  Lang Jia; Yun Zhang; Feng Pu; Chong Yang; Shula Yang; Jinze Yu; Zihan Xu; Hongji Yang; Yu Zhou; Shikai Zhu
Journal:  Aging (Albany NY)       Date:  2022-02-27       Impact factor: 5.682
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.